Molecular-cellular features of macrophage reaction in granulomatous pulmonary diseases

S. Arifkhanova, R. Isroilov (Tashkent, Uzbekistan)

Source: Annual Congress 2007 - Novel mediators of cellular pathology
Session: Novel mediators of cellular pathology
Session type: Electronic Poster Discussion
Number: 3071
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Arifkhanova, R. Isroilov (Tashkent, Uzbekistan). Molecular-cellular features of macrophage reaction in granulomatous pulmonary diseases. Eur Respir J 2007; 30: Suppl. 51, 3071

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary involvement in inflammatory myopathies
Source: Eur Respir Monogr 2019; 86: 68-89
Year: 2019


Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Source: Eur Respir J 2009; 33: 1498-1502
Year: 2009



IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Eur Respir J 2015; 45: 1613-1623
Year: 2015



Cytokines profile in granulomatous lung disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 374s
Year: 2005

Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011


Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002



How to treat bronchial granuloma in chronic granulomatous disease?
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

Pathology of pulmonary involvement in inflammatory bowel disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=199
Year: 2007

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Inflammatory pathways leading to pulmonary arterial hypertension in connective tissue diseases
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008


Pulmonary manifestation of chronic granulomatous disease (CGD)
Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Year: 2010


Macrophage derived inflammatory mediators and thoracic HRCT scoring in scleroderma fibrosing alveolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002

Characteristics of inflammatory bowel diseases-associated interstitial lung diseases
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011


Women: lung and autoimmune disease
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190
Year: 2003

Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006

Emergencies in interstitial and immunological lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177
Year: 2006

Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

How systemic inflammatory diseases affect the lung
Source: Virtual Congress 2020 – Interstitial lung diseases
Year: 2020